LogicBio Therapeutics Interest Expense | LOGC

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense LogicBio Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.07 M	1.1 M	546 K	2 K	67 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.1 M	2 K	557 K

Quarterly Interest Expense LogicBio Therapeutics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	176 K	197 K	218 K	-	270 K	283 K	271 K	-	276 K	273 K	272 K	-	271 K	-1 K	3 K	-	-154 K	-7 K	3 K	-	37 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
283 K	-154 K	149 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Brickell Biotech BBI	5 K	-	-5.38 %	$ 6.06 M	USA
Applied Therapeutics APLT	-77 K	-	-	$ 8.42 M	USA
Merus N.V. MRUS	1.06 M	-	-	$ 5.78 B	Niderland
Annexon ANNX	57 K	$ 4.2	-0.71 %	$ 651 M	USA
AbbVie ABBV	2.89 B	$ 293.87	0.19 %	$ 520 B	USA
Alnylam Pharmaceuticals ALNY	5.2 M	$ 151.6	-3.2 %	$ 19.9 B	USA
Galmed Pharmaceuticals Ltd. GLMD	741 K	$ 4.63	21.05 %	$ 20 M	Israel
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
Axon Enterprise AXON	99.9 M	$ 302.6	-0.19 %	$ 23.6 B	USA
Liquidia Corporation LQDA	6.27 M	$ 51.37	7.31 %	$ 4.42 B	USA
CRISPR Therapeutics AG CRSP	86.6 M	$ 45.05	-9.97 %	$ 4.05 B	Schweiz
Scholar Rock Holding Corporation SRRK	-301 K	$ 48.48	-5.96 %	$ 5.56 B	USA
Geron Corporation GERN	-375 K	$ 0.96	-3.71 %	$ 640 M	USA
Bristol-Myers Squibb Company BMY	-674 M	$ 62.8	1.06 %	$ 128 B	USA
Titan Pharmaceuticals TTNP	2 K	-	-3.76 %	$ 3.47 M	USA
Kazia Therapeutics Limited KZIA	1 K	$ 7.4	-0.13 %	$ 113 M	Australia
Celldex Therapeutics CLDX	927 K	$ 30.68	-1.81 %	$ 2.04 B	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Ligand Pharmaceuticals Incorporated LGND	-89 K	$ 317.26	0.99 %	$ 6.14 B	USA
Eli Lilly and Company LLY	-25.4 M	$ 1 432.7	1.47 %	$ 1.29 T	USA
Crinetics Pharmaceuticals CRNX	-357 K	$ 84.95	0.13 %	$ 7.99 B	USA
TFF Pharmaceuticals TFFP	14.5 K	-	-60.05 %	$ 125 K	USA
Mesoblast Limited MESO	21.8 M	$ 14.0	-3.06 %	$ 16.9 B	Australia
CorMedix CRMD	1.4 M	$ 5.37	-2.1 %	$ 387 K	USA
Adaptimmune Therapeutics plc ADAP	-1.73 M	-	-15.15 %	$ 60.3 M	Britain
MannKind Corporation MNKD	-1.01 M	$ 4.22	0.84 %	$ 1.29 B	USA
AVEO Pharmaceuticals AVEO	1.6 M	-	-	$ 521 M	USA
MediciNova MNOV	-12.8 K	$ 1.4	-4.76 %	$ 68.7 M	USA
Merck & Co. MRK	-151 M	$ 147.75	-0.68 %	$ 370 B	USA
Moderna MRNA	-8 M	$ 250.79	-6.77 %	$ 97.6 B	USA
Axcella Health AXLA	3.02 M	-	-16.42 %	$ 249 M	USA
Dynavax Technologies Corporation DVAX	293 K	-	-	$ 2.02 B	USA
Intellia Therapeutics NTLA	28.3 M	$ 11.18	-7.72 %	$ 1.21 B	USA
Novartis AG NVS	1.14 B	$ 163.39	-0.18 %	$ 317 B	Schweiz
Omeros Corporation OMER	30.8 M	$ 17.3	-1.48 %	$ 1.1 B	USA
Oramed Pharmaceuticals ORMP	-606 K	$ 3.97	-0.75 %	$ 164 M	Israel
Tyme Technologies TYME	70.2 K	-	8.07 %	$ 54 M	USA
Puma Biotechnology PBYI	1.03 M	$ 8.13	-3.22 %	$ 407 M	USA